# Thrombolysis of Urokinase for Minor Stroke

> **NCT04420351** · PHASE3 · COMPLETED · sponsor: **The First Affiliated Hospital of Zhengzhou University** · enrollment: 1005 (actual)

## Conditions studied

- Minor Stroke

## Interventions

- **DRUG:** Urokinase thrombolysis
- **DRUG:** Aspirin;Clopidogrel

## Key facts

- **NCT ID:** NCT04420351
- **Lead sponsor:** The First Affiliated Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-04
- **Primary completion:** 2023-02-18
- **Final completion:** 2023-02-18
- **Target enrollment:** 1005 (ACTUAL)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04420351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04420351, "Thrombolysis of Urokinase for Minor Stroke". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04420351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*